Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

ICMR-licensed SHETA2 drug could replace surgery for early cervical cancer

Posted on August 4, 2026
By Bing News
0 Views
1 min read

In brief

Generating AI summary…

ICMR-licensed SHETA2 drug could replace surgery for early cervical cancer

The development comes as India continues to carry one of the world's highest cervical cancer burdens. According to the World Health Organisation, cervical cancer remains the second most common cancer among Indian women after breast cancer.